zofenopril 30 to 60 mg/day once daily was as effective as atenolol 50 to 100 mg/day, amlodipine 5 to 10 mg/day and enalapril 20 to 40 mg/day when assessed by reductions in diastolic BP.

(12.5-25.0 mg/day) and treatment with each of three other types of antihypertensive drugs -- a calcium-channel blocker (amlodipine), an angiotensin-converting enzyme inhibitor (lisinopril), and a ...

Like most people who have been diagnosed with a life-threatening disease, Ruel Bautista is still trying to come to terms with ...

The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...

The 5 mg risdiplam tablet provides the same efficacy and safety for spinal muscular atrophy as the currently available oral ...

The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...

Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...

The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Owning a four-wheeler is the dream of many people, not only in the Philippines. However, with the current high car import tax rate, many people choose to buy used cars for sale to save maximum costs.

The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...